Efficacy and Safety of Psychedelics in Treating Anxiety Disorders
Conclusion: Based on the evidence of symptom reduction and safety, the current literature (2011 to 2021) shows that psychedelics could be considered for treating clinician-diagnosed anxiety disorders. Psychedelics may provide an alternative therapeutic option for patients resistant to current standard treatments.PMID:38143548 | PMC:PMC10741816 | DOI:10.31486/toj.23.0076
Source: Ochsner Journal - Category: General Medicine Authors: Leah Feulner Thanpicha Sermchaiwong Nathan Rodland David Galarneau Source Type: research
More News: Agoraphobia | Anxiety | Clinical Trials | General Medicine | Generalized Anxiety Disorder (GAD) | Nutrition | Panic Disorder | Separation Anxiety | Social Anxiety Disorder | Study